Covid: los avances en vacunas contrastan con la frustrante lentitud para dar con los antivirales cronista.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cronista.com Daily Mail and Mail on Sunday newspapers.
Antiviral drug thapsigargin effective against Covid, suggests study
February 04, 2021
Researchers believe it will help mitigate future outbreaks
Researchers, including those from the University of Nottingham in the UK, have found an antiviral drug that is highly effective against the novel coronavirus.
The researchers of the study believe that the administration of the drug thapsigargin will help in mitigating future outbreaks.
They stated in their study that the plant-derived antiviral, in small doses, stimulates a highly effective host-centred antiviral innate immune response against three major types of human respiratory viruses. This includes Covid-19.
According to the study, an antiviral of this type could potentially be made available for community use to control active infection and its spread.
He called for funding and political backing for the new drug.
“The whole beauty of TG is that if you can catch Covid early, everything is a lot simpler downstream, Prof Chang said.
“You don t develop a serious illness and you stop the spread of Covid in its tracks.”
Given that acute respiratory infections caused by different viruses are clinically indistinguishable at first, an effective broad-spectrum drug that can fight different virus types at the same time could significantly improve clinical management and control active infection and its spread.
The research team discovered recently that TG can make cells highly resistant to infection by starting responses that disrupt the reproduction cycle of viruses, such as Covid-19, in several places at the same time.
Найден весьма эффективный против COVID-19 препарат ria.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ria.ru Daily Mail and Mail on Sunday newspapers.